☆ 4.7 Review

Treatment and Prognosis of COVID-19 Associated Olfactory and Gustatory Dysfunctions

JOURNAL OF PERSONALIZED MEDICINE (2021)

Related references

Note: Only part of the references are listed.

Article Radiology, Nuclear Medicine & Medical Imaging

Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia

Sedat Giray Kandemirli et al.

Summary: This study evaluated 23 patients with persistent COVID-19 olfactory dysfunction, finding olfactory cleft and olfactory bulb abnormalities to be common in cases of COVID-19 anosmia. The study also revealed a relatively high percentage of olfactory bulb degeneration, indicating a need for further longitudinal imaging studies to better understand the mechanism of olfactory neuronal pathway injury in COVID-19 anosmia.

ACADEMIC RADIOLOGY (2021)

Add to Collection

Article Clinical Neurology

COVID-19-induced anosmia associated with olfactory bulb atrophy

Andrew Chiu et al.

Summary: Olfactory loss in COVID-19 patients could be a neurological marker of coronavirus infection and requires further investigation through imaging studies.

NEURORADIOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

The temporal course of COVID-19 anosmia and relation to other clinical symptoms

Aytug Altundag et al.

Summary: This study aimed to investigate the clinical course of anosmia in relation to other symptoms among COVID-19 patients. The results showed that isolated anosmia cases had more severe symptoms and lower complete recovery rates compared to patients with other clinical symptoms. Residual olfactory dysfunction and duration of loss of smell varied between different groups.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell

Serge-Daniel Le Bon et al.

Summary: This pilot study suggests that the combination of a short course of oral corticosteroids and olfactory training is safe and beneficial in helping patients with enduring dysosmia recover from olfactory loss due to COVID-19. Larger cohorts are needed to further investigate and confirm these findings.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients

J. R. Lechien et al.

Summary: This study found that olfactory dysfunction (OD) is more prevalent in mild cases of COVID-19 compared to moderate-to-critical forms. Additionally, 24.1% of patients did not subjectively recover olfaction 60 days after the onset of the dysfunction. Objective olfactory evaluations identified hyposmia/anosmia in a significant percentage of patients, with higher baseline severity of objective olfactory evaluations strongly predictive of persistent OD.

JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients

Jeyasakthy Saniasiaya et al.

Summary: A systematic review and meta-analysis found that the overall prevalence of olfactory dysfunction in COVID-19 patients is 47.85%, with European patients having the highest prevalence and Asian patients the lowest. Discrepancies between objective and subjective evaluations suggest further studies are needed.

LARYNGOSCOPE (2021)

Add to Collection

Article Otorhinolaryngology

Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial

Abdelrahman Ahmed Abdelalim et al.

Summary: The study found that using mometasone furoate nasal spray as a topical corticosteroid for post COVID-19 anosmia did not offer significant benefits over olfactory training, with no statistical differences in treatment outcomes and recovery rates.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Add to Collection

Article Behavioral Sciences

Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This study found that as the time since virus infection increases, olfactory dysfunction becomes more common among patients, with a high percentage showing persistent dysfunction despite most patients subjectively reporting normal smell.

CHEMICAL SENSES (2021)

Add to Collection

Article Otorhinolaryngology

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients

Chandra Veer Singh et al.

Summary: The study demonstrated that the use of fluticasone nasal spray and triamcinolone paste significantly improved olfactory and taste function in COVID-19 patients, with faster recovery compared to the control group.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers

Juan Riestra-Ayora et al.

Summary: In COVID-19 patients, olfactory and gustatory dysfunction showed high-resolution rates within the first two months after onset, but 11% did not fully recover and 30% partially recovered after 6 months. There was a high correlation between olfactory and gustatory dysfunction, while nasal obstruction and dyspnea were identified as risk factors for symptom persistence.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Add to Collection

Article Health Care Sciences & Services

Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study

Fabrice Denis et al.

Summary: This study found that olfactory training and visual stimulation assisted by a dedicated web application significantly improved olfaction in patients, especially after at least 28 days of olfactory training.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Add to Collection

Article Cell Biology

COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters

Guilherme Dias de Melo et al.

Summary: Recent investigations have shown that olfactory and taste dysfunction are common in mildly symptomatic COVID-19 patients. Research on the olfactory neuroepithelium revealed that SARS-CoV-2 infection can cause local inflammation and lead to acute loss of smell, which may account for prolonged symptoms of COVID-19 such as anosmia.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Otorhinolaryngology

Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view

Caroline Huart et al.

Summary: The frequent association between COVID-19 and olfactory dysfunction is leading to a demand for treatment, with systemic corticosteroids considered as an option. However, caution is advised due to weak evidence supporting their effectiveness, high rate of spontaneous recovery, and potential adverse effects. Instead, smell training, which has strong evidence and no known side effects, should be considered initially.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study

Rasheed Ali Rashid et al.

Summary: A clinical trial evaluating the therapeutic effect of nasal betamethasone drops in COVID-19-associated anosmia showed no significant impact on the recovery time compared to placebo. Age, smoking status, duration of anosmia, and co-presentation of ageusia with anosmia are important determinants for the recovery time of anosmia. Additional clinical trials taking these covariates into account are necessary.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Add to Collection

Article Behavioral Sciences

Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers

Nicholas Bussiere et al.

Summary: Studies have shown that some COVID-19 patients may experience chemosensory alterations or impairments. A research on 704 healthcare workers revealed that a significant proportion of infected individuals still have chemosensory impairments 3-7 months after their infection.

CHEMICAL SENSES (2021)

Add to Collection

Article Immunology

Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial

Hossein Kasiri et al.

Summary: The study aimed to evaluate the usage of mometasone furoate nasal spray in patients with severe microsmia or anosmia induced by COVID-19. The combination of mometasone furoate nasal spray with olfactory training showed greater improvement in patients with severe chronic anosmia by COVID-19 compared to olfactory training alone.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Microbiology

Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study

Sven Saussez et al.

Summary: The early use of oral corticosteroids or nasal corticosteroids in combination with olfactory training seems to have better efficacy in improving COVID-19 related olfactory dysfunction compared to olfactory training alone, but the long-term outcomes remain uncertain, requiring further research to validate.

PATHOGENS (2021)

Add to Collection

Article Medicine, General & Internal

Clinical Features of Olfactory Dysfunction in COVID-19 Patients

Min Young Seo et al.

Summary: This study found that the subjective olfactory function significantly decreased in COVID-19 patients with olfactory dysfunction, but the objective olfactory function was not significantly different. 70% of patients recovered their olfactory function after 2 months of olfactory training.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Add to Collection

Article Behavioral Sciences

Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This study prospectively assessed the 6-month prevalence of olfactory dysfunction in subjects with mild-to-moderate COVID-19. Despite most patients reporting a subjectively normal sense of smell, a high percentage of persistent smell dysfunction was observed at 6 months, highlighting a significant long-term rate of smell alteration in patients with previous SARS-CoV-2 infection.

CHEMICAL SENSES (2021)

Add to Collection

Article Medicine, General & Internal

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Editorial Material Clinical Neurology

Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia

Letterio S. Politi et al.

JAMA NEUROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia

Abolfazl Torabi et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

COVID-19, cilia, and smell

Wei Li et al.

FEBS JOURNAL (2020)

Add to Collection

Article Medicine, Research & Experimental

COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction

Ryan H. W. Cho et al.

LARYNGOSCOPE (2020)

Add to Collection

Article Otorhinolaryngology

Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Add to Collection

Article Otorhinolaryngology

Early recovery patterns of olfactory disorders in COVID-19 patients; a clinical cohort study

Mohamed A. Amer et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Trend of Olfactory and Gustatory Dysfunction in COVID-19 Patients in a Quarantine Facility

Min Young Seo et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

Add to Collection

Review Otorhinolaryngology

Self-reported alteration of sense of smell or taste in patients with COVID-19: a systematic review and meta-analysis on 3563 patients

Daniele Borsetto et al.

RHINOLOGY (2020)

Add to Collection

Article Otorhinolaryngology

Clinical practice guidelines for the management of olfactory dysfunction - Secondary publication

Takaki Miwa et al.

AURIS NASUS LARYNX (2019)

Add to Collection

Article Medicine, Research & Experimental

Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study

Michael Damm et al.

LARYNGOSCOPE (2014)

Add to Collection

Article Medicine, Research & Experimental

Effects of Olfactory Training in Patients with Olfactory Loss

Thomas Hummel et al.

LARYNGOSCOPE (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.